Viemed Healthcare, Inc. (NASDAQ: VMD) Stock Competitors & Peer Comparison
See VMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VMD | $8.79 | -1.72% | 326.4M | 23.81 | $0.36 | N/A |
| HCA | $430.71 | +5.81% | 88B | 14.03 | $28.96 | +0.74% |
| THC | $277.98 | +3.52% | 22B | 15.81 | $17.24 | N/A |
| FMS | $23.46 | -1.61% | 12.6B | 8.80 | $2.66 | +3.68% |
| EHC | $120.76 | -0.81% | 12B | 20.72 | $5.84 | +0.63% |
| BTSGU | $195.42 | -0.10% | 11.5B | 177.51 | $1.11 | N/A |
| DVA | $174.99 | -1.29% | 11.3B | 13.70 | $12.80 | N/A |
| ENSG | $179.58 | -1.59% | 10.5B | 26.07 | $6.90 | +0.14% |
| UHS | $176.29 | +2.30% | 10.5B | 7.67 | $22.54 | +0.46% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
VMD vs HCA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, HCA has a market cap of 88B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while HCA trades at $430.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas HCA's P/E ratio is 14.03. In terms of profitability, VMD's ROE is +0.10%, compared to HCA's ROE of -1.13%. Regarding short-term risk, VMD is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
VMD vs THC Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, THC has a market cap of 22B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while THC trades at $277.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas THC's P/E ratio is 15.81. In terms of profitability, VMD's ROE is +0.10%, compared to THC's ROE of +0.51%. Regarding short-term risk, VMD is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
VMD vs FMS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, FMS has a market cap of 12.6B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while FMS trades at $23.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas FMS's P/E ratio is 8.80. In terms of profitability, VMD's ROE is +0.10%, compared to FMS's ROE of +0.07%. Regarding short-term risk, VMD is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
VMD vs EHC Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, EHC has a market cap of 12B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while EHC trades at $120.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas EHC's P/E ratio is 20.72. In terms of profitability, VMD's ROE is +0.10%, compared to EHC's ROE of +0.25%. Regarding short-term risk, VMD is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
VMD vs BTSGU Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while BTSGU trades at $195.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas BTSGU's P/E ratio is 177.51. In terms of profitability, VMD's ROE is +0.10%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, VMD is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for VMD.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
VMD vs DVA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, DVA has a market cap of 11.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while DVA trades at $174.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas DVA's P/E ratio is 13.70. In terms of profitability, VMD's ROE is +0.10%, compared to DVA's ROE of -1.24%. Regarding short-term risk, VMD is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
VMD vs ENSG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ENSG has a market cap of 10.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ENSG trades at $179.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ENSG's P/E ratio is 26.07. In terms of profitability, VMD's ROE is +0.10%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, VMD is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
VMD vs UHS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, UHS has a market cap of 10.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while UHS trades at $176.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas UHS's P/E ratio is 7.67. In terms of profitability, VMD's ROE is +0.10%, compared to UHS's ROE of +0.21%. Regarding short-term risk, VMD is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
VMD vs OSH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas OSH's P/E ratio is -17.65. In terms of profitability, VMD's ROE is +0.10%, compared to OSH's ROE of +4.64%. Regarding short-term risk, VMD is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
VMD vs CHE Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CHE has a market cap of 7B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CHE trades at $540.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CHE's P/E ratio is 24.74. In terms of profitability, VMD's ROE is +0.10%, compared to CHE's ROE of +0.29%. Regarding short-term risk, VMD is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for VMD.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
VMD vs PACS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, PACS has a market cap of 6.9B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while PACS trades at $44.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas PACS's P/E ratio is 23.06. In terms of profitability, VMD's ROE is +0.10%, compared to PACS's ROE of +0.27%. Regarding short-term risk, VMD is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check PACS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
VMD vs LHCG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas LHCG's P/E ratio is 82.83. In terms of profitability, VMD's ROE is +0.10%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, VMD is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
VMD vs LFST Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while LFST trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas LFST's P/E ratio is 95.28. In terms of profitability, VMD's ROE is +0.10%, compared to LFST's ROE of +0.03%. Regarding short-term risk, VMD is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for VMD.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
VMD vs CON Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CON trades at $35.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CON's P/E ratio is 24.18. In terms of profitability, VMD's ROE is +0.10%, compared to CON's ROE of +0.47%. Regarding short-term risk, VMD is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for VMD.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
VMD vs NHC Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NHC has a market cap of 3.7B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NHC trades at $232.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NHC's P/E ratio is 30.00. In terms of profitability, VMD's ROE is +0.10%, compared to NHC's ROE of +0.13%. Regarding short-term risk, VMD is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for VMD.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
VMD vs OPCH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while OPCH trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas OPCH's P/E ratio is 13.66. In terms of profitability, VMD's ROE is +0.10%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, VMD is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
VMD vs AMED Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AMED's P/E ratio is 39.30. In terms of profitability, VMD's ROE is +0.10%, compared to AMED's ROE of +0.11%. Regarding short-term risk, VMD is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
VMD vs AVAH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AVAH has a market cap of 2.8B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AVAH trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AVAH's P/E ratio is 19.07. In terms of profitability, VMD's ROE is +0.10%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, VMD is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
VMD vs BKD Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while BKD trades at $11.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas BKD's P/E ratio is -20.35. In terms of profitability, VMD's ROE is +0.10%, compared to BKD's ROE of +4.06%. Regarding short-term risk, VMD is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for VMD.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
VMD vs ACHC Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ACHC trades at $27.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ACHC's P/E ratio is 13.55. In terms of profitability, VMD's ROE is +0.10%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, VMD is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
VMD vs GRDN Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while GRDN trades at $37.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas GRDN's P/E ratio is 32.92. In terms of profitability, VMD's ROE is +0.10%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, VMD is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for VMD.Check GRDN's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
VMD vs ADUS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ADUS has a market cap of 2.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ADUS trades at $121.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ADUS's P/E ratio is 18.05. In terms of profitability, VMD's ROE is +0.10%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, VMD is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
VMD vs MD Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, MD has a market cap of 2.1B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while MD trades at $26.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas MD's P/E ratio is 11.68. In terms of profitability, VMD's ROE is +0.10%, compared to MD's ROE of +0.20%. Regarding short-term risk, VMD is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
VMD vs SEM Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SEM's P/E ratio is 15.43. In terms of profitability, VMD's ROE is +0.10%, compared to SEM's ROE of +0.08%. Regarding short-term risk, VMD is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
VMD vs ASTH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ASTH trades at $38.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ASTH's P/E ratio is 37.25. In terms of profitability, VMD's ROE is +0.10%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, VMD is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
VMD vs SNDA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SNDA trades at $39.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SNDA's P/E ratio is -7.27. In terms of profitability, VMD's ROE is +0.10%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, VMD is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
VMD vs AMEH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AMEH's P/E ratio is 39.25. In terms of profitability, VMD's ROE is +0.10%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, VMD is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AMEH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
VMD vs SGRY Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SGRY trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SGRY's P/E ratio is 35.74. In terms of profitability, VMD's ROE is +0.10%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, VMD is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SGRY's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
VMD vs HCSG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while HCSG trades at $22.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas HCSG's P/E ratio is 18.40. In terms of profitability, VMD's ROE is +0.10%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, VMD is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
VMD vs AGL Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AGL trades at $94.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AGL's P/E ratio is -10.38. In terms of profitability, VMD's ROE is +0.10%, compared to AGL's ROE of -1.19%. Regarding short-term risk, VMD is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
VMD vs ARDT Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ARDT trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ARDT's P/E ratio is 8.46. In terms of profitability, VMD's ROE is +0.10%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, VMD is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
VMD vs INNV Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while INNV trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas INNV's P/E ratio is -119.11. In terms of profitability, VMD's ROE is +0.10%, compared to INNV's ROE of -0.09%. Regarding short-term risk, VMD is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for VMD.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
VMD vs PNTG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while PNTG trades at $39.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas PNTG's P/E ratio is 29.65. In terms of profitability, VMD's ROE is +0.10%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, VMD is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
VMD vs AMN Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AMN trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AMN's P/E ratio is 11.56. In terms of profitability, VMD's ROE is +0.10%, compared to AMN's ROE of +0.15%. Regarding short-term risk, VMD is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
VMD vs NUTX Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NUTX trades at $187.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NUTX's P/E ratio is 14.57. In terms of profitability, VMD's ROE is +0.10%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, VMD is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
VMD vs BKDT Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas BKDT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, VMD is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for VMD.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
VMD vs USPH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while USPH trades at $79.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas USPH's P/E ratio is 30.70. In terms of profitability, VMD's ROE is +0.10%, compared to USPH's ROE of -0.01%. Regarding short-term risk, VMD is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
VMD vs TALK Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TALK's P/E ratio is 774.34. In terms of profitability, VMD's ROE is +0.10%, compared to TALK's ROE of +0.00%. Regarding short-term risk, VMD is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
VMD vs FSHCX Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, FSHCX has a market cap of 868.3M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while FSHCX trades at $113.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas FSHCX's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to FSHCX's ROE of N/A. Regarding short-term risk, VMD is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
VMD vs GMRS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, GMRS has a market cap of 765.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while GMRS trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas GMRS's P/E ratio is 6.30. In terms of profitability, VMD's ROE is +0.10%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, VMD is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
VMD vs EHAB Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas EHAB's P/E ratio is -197.14. In terms of profitability, VMD's ROE is +0.10%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, VMD is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for VMD.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
VMD vs STLN Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, STLN has a market cap of 653.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while STLN trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas STLN's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to STLN's ROE of +2.10%. Regarding short-term risk, VMD is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for VMD.Check STLN's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
VMD vs SRTA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SRTA has a market cap of 515.7M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SRTA trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SRTA's P/E ratio is -28.09. In terms of profitability, VMD's ROE is +0.10%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, VMD is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
VMD vs TOI Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TOI's P/E ratio is -14.25. In terms of profitability, VMD's ROE is +0.10%, compared to TOI's ROE of +2.10%. Regarding short-term risk, VMD is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
VMD vs MCTA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas MCTA's P/E ratio is 419.36. In terms of profitability, VMD's ROE is +0.10%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, VMD is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
VMD vs CYH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CYH has a market cap of 420.1M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CYH trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CYH's P/E ratio is 4.08. In terms of profitability, VMD's ROE is +0.10%, compared to CYH's ROE of +0.21%. Regarding short-term risk, VMD is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
VMD vs AUNA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AUNA trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AUNA's P/E ratio is 4.73. In terms of profitability, VMD's ROE is +0.10%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, VMD is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AUNA's competition here
Capital Senior Living Corporation (NYSE: CSU)
VMD vs CSU Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CSU's P/E ratio is 0.67. In terms of profitability, VMD's ROE is +0.10%, compared to CSU's ROE of -0.33%. Regarding short-term risk, VMD is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
VMD vs AIRS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AIRS has a market cap of 188.4M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AIRS's P/E ratio is -89.00. In terms of profitability, VMD's ROE is +0.10%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, VMD is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
VMD vs JYNT Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, JYNT has a market cap of 117.6M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while JYNT trades at $8.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas JYNT's P/E ratio is 82.50. In terms of profitability, VMD's ROE is +0.10%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, VMD is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for VMD.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
VMD vs FVE Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas FVE's P/E ratio is -5.64. In terms of profitability, VMD's ROE is +0.10%, compared to FVE's ROE of -0.15%. Regarding short-term risk, VMD is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FVE's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
VMD vs PARK Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, PARK has a market cap of 97.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while PARK trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas PARK's P/E ratio is 29.30. In terms of profitability, VMD's ROE is +0.10%, compared to PARK's ROE of -0.18%. Regarding short-term risk, VMD is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for VMD.Check PARK's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
VMD vs KDLYW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas KDLYW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, VMD is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
VMD vs BTMD Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, BTMD has a market cap of 62.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while BTMD trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas BTMD's P/E ratio is 12.82. In terms of profitability, VMD's ROE is +0.10%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, VMD is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for VMD.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
VMD vs ALR Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ALR's P/E ratio is -1.11. In terms of profitability, VMD's ROE is +0.10%, compared to ALR's ROE of -0.15%. Regarding short-term risk, VMD is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
VMD vs DCGO Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, DCGO has a market cap of 42.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while DCGO trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas DCGO's P/E ratio is -0.23. In terms of profitability, VMD's ROE is +0.10%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, VMD is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for VMD.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
VMD vs CCEL Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CCEL has a market cap of 33.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CCEL trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CCEL's P/E ratio is -14.00. In terms of profitability, VMD's ROE is +0.10%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, VMD is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CCEL's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
VMD vs PIII Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, PIII has a market cap of 33.6M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while PIII trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas PIII's P/E ratio is -0.26. In terms of profitability, VMD's ROE is +0.10%, compared to PIII's ROE of +1.61%. Regarding short-term risk, VMD is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for VMD.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
VMD vs IMAC Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas IMAC's P/E ratio is -2.27. In terms of profitability, VMD's ROE is +0.10%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, VMD is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check IMAC's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
VMD vs EUDA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, EUDA has a market cap of 26.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while EUDA trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas EUDA's P/E ratio is -26.79. In terms of profitability, VMD's ROE is +0.10%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, VMD is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
VMD vs CANO-WT Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, VMD is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
VMD vs AIH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AIH's P/E ratio is -2.78. In terms of profitability, VMD's ROE is +0.10%, compared to AIH's ROE of +1.16%. Regarding short-term risk, VMD is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
VMD vs CANO Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CANO's P/E ratio is -0.01. In terms of profitability, VMD's ROE is +0.10%, compared to CANO's ROE of -1.49%. Regarding short-term risk, VMD is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
VMD vs FPCG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas FPCG's P/E ratio is 0.09. In terms of profitability, VMD's ROE is +0.10%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, VMD is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
VMD vs AMS Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AMS has a market cap of 10M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AMS trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AMS's P/E ratio is -6.79. In terms of profitability, VMD's ROE is +0.10%, compared to AMS's ROE of -0.07%. Regarding short-term risk, VMD is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
VMD vs FTRP Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas FTRP's P/E ratio is -1.22. In terms of profitability, VMD's ROE is +0.10%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, VMD is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for VMD.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
VMD vs BMGL Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while BMGL trades at $4.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas BMGL's P/E ratio is -0.92. In terms of profitability, VMD's ROE is +0.10%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, VMD is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
VMD vs XWEL Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, XWEL has a market cap of 7.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while XWEL trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas XWEL's P/E ratio is -0.18. In terms of profitability, VMD's ROE is +0.10%, compared to XWEL's ROE of +3.18%. Regarding short-term risk, VMD is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
VMD vs MODV Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas MODV's P/E ratio is -0.06. In terms of profitability, VMD's ROE is +0.10%, compared to MODV's ROE of +1.36%. Regarding short-term risk, VMD is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MODV's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
VMD vs AIDX Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AIDX has a market cap of 6.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AIDX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AIDX's P/E ratio is -0.95. In terms of profitability, VMD's ROE is +0.10%, compared to AIDX's ROE of +1.76%. Regarding short-term risk, VMD is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIDX's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
VMD vs STLNW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, STLNW has a market cap of 5.8M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas STLNW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to STLNW's ROE of N/A. Regarding short-term risk, VMD is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check STLNW's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
VMD vs GBNH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas GBNH's P/E ratio is -0.06. In terms of profitability, VMD's ROE is +0.10%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, VMD is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
VMD vs RHE-PA Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, VMD's ROE is +0.10%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, VMD is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
VMD vs RHE Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas RHE's P/E ratio is -1.79. In terms of profitability, VMD's ROE is +0.10%, compared to RHE's ROE of -1.31%. Regarding short-term risk, VMD is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for VMD.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
VMD vs TOIIW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, VMD's ROE is +0.10%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, VMD is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
VMD vs IMACW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas IMACW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, VMD is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
VMD vs NAKAW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, VMD's ROE is +0.10%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, VMD is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
VMD vs CCM Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, CCM has a market cap of 741.2K. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while CCM trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas CCM's P/E ratio is -0.34. In terms of profitability, VMD's ROE is +0.10%, compared to CCM's ROE of +0.06%. Regarding short-term risk, VMD is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
VMD vs NIVF Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NIVF has a market cap of 105.7K. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NIVF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NIVF's P/E ratio is 0.27. In terms of profitability, VMD's ROE is +0.10%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, VMD is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for VMD.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
VMD vs MNDR Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, MNDR has a market cap of 42.1K. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while MNDR trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas MNDR's P/E ratio is -0.04. In terms of profitability, VMD's ROE is +0.10%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, VMD is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for VMD.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
VMD vs NIVFW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, VMD's ROE is +0.10%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, VMD is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
VMD vs TALKW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TALKW's P/E ratio is 0.00. In terms of profitability, VMD's ROE is +0.10%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, VMD is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TALKW's competition here
New Frontier Health Corporation (NYSE: NFH)
VMD vs NFH Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, NFH has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas NFH's P/E ratio is -19.75. In terms of profitability, VMD's ROE is +0.10%, compared to NFH's ROE of -0.06%. Regarding short-term risk, VMD is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NFH's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
VMD vs ATIP-WT Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, VMD is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
VMD vs HNGR Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas HNGR's P/E ratio is 19.71. In terms of profitability, VMD's ROE is +0.10%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, VMD is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
VMD vs SLHG Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SLHG's P/E ratio is -1.48. In terms of profitability, VMD's ROE is +0.10%, compared to SLHG's ROE of N/A. Regarding short-term risk, VMD is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SLHG's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
VMD vs DVCR Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas DVCR's P/E ratio is 28.34. In terms of profitability, VMD's ROE is +0.10%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, VMD is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
VMD vs AFAM Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas AFAM's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, VMD is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AFAM's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
VMD vs TVTY Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TVTY's P/E ratio is 19.06. In terms of profitability, VMD's ROE is +0.10%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, VMD is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TVTY's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
VMD vs TLMD Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TLMD's P/E ratio is -1.60. In terms of profitability, VMD's ROE is +0.10%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, VMD is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TLMD's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
VMD vs TLMDW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas TLMDW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, VMD is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TLMDW's competition here
DocGo Inc. (NASDAQ: DCGOW)
VMD vs DCGOW Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas DCGOW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, VMD is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check DCGOW's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
VMD vs SLHGP Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, VMD's ROE is +0.10%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, VMD is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SLHGP's competition here
Kindred Healthcare, Inc. (NYSE: KND)
VMD vs KND Comparison August 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 326.4M. In comparison, KND has a market cap of 0. Regarding current trading prices, VMD is priced at $8.79 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 23.81, whereas KND's P/E ratio is -1.14. In terms of profitability, VMD's ROE is +0.10%, compared to KND's ROE of -0.53%. Regarding short-term risk, VMD is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for VMD.Check KND's competition here